ANTIPHOSPHOLIPID ANTIBODIES IN PATIENTS WITH EOSINOPHILIA MYALGIA ANDTOXIC OIL SYNDROME

Citation
Pe. Carreira et al., ANTIPHOSPHOLIPID ANTIBODIES IN PATIENTS WITH EOSINOPHILIA MYALGIA ANDTOXIC OIL SYNDROME, Journal of rheumatology, 24(1), 1997, pp. 69-72
Citations number
26
Categorie Soggetti
Rheumatology
Journal title
ISSN journal
0315162X
Volume
24
Issue
1
Year of publication
1997
Pages
69 - 72
Database
ISI
SICI code
0315-162X(1997)24:1<69:AAIPWE>2.0.ZU;2-5
Abstract
Objective, To explore whether antiphospholipid antibodies (aPL) are ma rkers of vascular related damage or merely evidence of toxic related a utoimmunity, we investigated the presence of different aPL in patients with toxic oil syndrome (TOS) and compared the profile with patients with eosinophilia myalgia syndrome (EMS). Methods, Reactivity against cardiolipin, P-serine, P-inositol, and P-choline was investigated by E LISA in the blood of 266 patients with acute and chronic TOS, 25 healt hy relatives of TOS patients, and 48 patients with EMS. Results, 32% o f TOS and 13% of EMS patients had IgG antibodies against cardiolipin a nd other polyanions. 20% of both TOS and EMS patients presented IgM an tibodies against anionic and zwitterionic phospholipids. 36% of TOS he althy relatives had IgM antibodies against differently charged phospho lipids. Among 200 patients with chronic TOS, there was no significant association between antibodies and clinical manifestations. Conclusion , aPL with different specificity are present in a high percentage of p atients with TOS and EMS. The significance of these antibodies remains unclear.